Deadline to Register for Duke Industry Symposium is August 28th

Recent Updates

Aug. 16, 2017

We are excited to announce that this year the Annual Duke Industry Statistics Symposium (DISS) will feature two eminent and provocative speakers.  Dr.  Warren Kibbe, former Acting Deputy Director of the National Cancer Institute and former Director of the NCI Center for Biomedical Informatics and Information Technology will give the opening keynote address, titled “Real World Evidence, EHR’s and Cancer Surveillance.”   Dr. Robert Califf, former FDA commissioner, will wrap-up the conference with a feature lecture “Evidence Generation in the Commercial (Sickness) real World vs the Health Real World: Motivation for Change?”  Dr. Kibbe relocated recently from NCI to Duke, where he is a professor in the Duke Department of Biostatistics and Bioinformatics and the Chief Data Officer for the Duke Cancer Institute.  Dr. Califf, was the former Vice Chancellor for Research at Duke before taking a leave of absence to serve at the FDA.  After leaving the FDA, he has taken leadership roles at both Duke and Verily Life Sciences. 

The conference will be held on September 6-8, 2017 at the Durham Hilton in Durham, NC.  The theme for this year will be “Real World Experience and Randomized Clinical Trials.” The purpose of the symposium is to discuss challenging issues and recent advances related to the clinical development of drugs, biologics and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.  Click here to register for this event.  

The program expanded again this year with additional short course offerings and more parallel sessions.  It will kick off with 8 Short Courses from experts all over the country from industry, government, and academia, followed by one and a half days of parallel sessions.  Click here to learn more about the event and to see the schedule of short courses, parallel sessions and poster session.

The Symposium is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, and co-sponsored by Amgen, Boehringer-Ingelheim, ICSA, Janssen, NC-ASA Chapter, PAREXEL, PPD, QuintilesIMS and SAS.